Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 1, 2011, Pages 123-129

  Närkiö Mäkelä, Mervi ^e   Mäkelä, Teppo ^b   Saarinen, Pia ^c   Salminen, Päivi ^c   Julkunen, Ilkka ^d   Pitkäranta, Anne ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e NONE

Author keywords

IP 10; Lymphatic malformation; OK 432; Systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PICIBANIL; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEAD AND NECK MALFORMATION; HUMAN; INFANT; LEUKOCYTE COUNT; LYMPHATIC MALFORMATION; LYMPHATIC SYSTEM DISEASE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROTHERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HEAD; HUMANS; INFANT; LYMPHATIC ABNORMALITIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECK; PICIBANIL; SCLEROTHERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 78751580645     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-010-1332-x     Document Type: Article

References (19)

1. M Hamoir I Plouin-Gaudon P Rombaux G Francois AS Cornu G Desuter P Clapuyt C Debauche G Verellen C Beguin 2001 Lymphatic malformations of the head and neck: a retrospective review and a support for staging Head Neck 4 326 337 10.1002/hed.1039
2. JJ Marler JB Mulliken 2001 Vascular anomalies: classification, diagnosis, and natural history Facial Plast Surg Clin North Am 4 495 504
3. B Banieghbal MR Davies 2003 Guidelines for the successful treatment of lymphangioma with OK-432 Eur J Pediatr Surg 2 103 107
4. CM Giguere NM Bauman Y Sato DK Burke JH Greinwald S Pransky P Kelley K Georgeson RJ Smith 2002 Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial Arch Otolaryngol Head Neck Surg 10 1137 1144
5. LJ Orvidas JL Kasperbauer 2000 Pediatric lymphangiomas of the head and neck Ann Otol Rhinol Laryngol 4 411 421
6. PE Burrows RK Mitri A Alomari HM Padua DJ Lord MB Sylvia SJ Fishman JB Mulliken 2008 Percutaneous sclerotherapy of lymphatic malformations with doxycycline Lymphat Res Biol 3-4 209 216 10.1089/lrb.2008.1004
7. R Rautio L Keski-Nisula J Laranne E Laasonen 2003 Treatment of lymphangiomas with OK-432 (Picibanil) Cardiovasc Intervent Radiol 1 31 36
8. Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ, OK-432 Collaborative Study Group (2009) Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 1:107-115
9. N Hall N Ade-Ajayi C Brewis DJ Roebuck EM Kiely DP Drake L Spitz A Pierro 2003 Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? Surgery 3 238 242 10.1067/msy.2003.62
10. S Ogita T Tsuto K Tokiwa T Takahashi 1987 Treatment of cystic hygroma in children with special reference to OK-432 therapy Z Kinderchir 5 279 281
11. A Fujino Y Moriya Y Morikawa K Hoshino T Watanabe N Shimojima M Kitajima 2003 A role of cytokines in OK-432 injection therapy for cystic lymphangioma: an approach to the mechanism J Pediatr Surg 12 1806 1809 10.1016/j.jpedsurg.2003. 08.041
12. S Ogita T Tsuto K Nakamura E Deguchi K Tokiwa N Iwai 1996 OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 4 477 480 10.1016/S0022-3468(96)90478-9
13. S Wiegand B Eivazi S Sel H Renz JA Werner BJ Folz 2008 Analysis of cytokine levels in human lymphangiomas In Vivo 22 253 256 1:CAS:528: DC%2BD1cXlsVemsr8%3D 18468411
14. Abbas AK, Lichtman AH (2005) Cytokines. In: Anonymous cellular and molecular immunology, 5th edn. Elsevier, Saunders, p 243
15. M Miettinen J Vuopio-Varkila K Varkila 1996 Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria Infect Immun 12 5403 5405
16. V Veckman M Miettinen S Matikainen R Lande E Giacomini EM Coccia I Julkunen 2003 Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis J Leukoc Biol 3 395 402 10.1189/jlb.0402212
17. ED Feldman DM Weinreich NM Carroll ML Burness AL Feldman E Turner H Xu HR Alexander Jr 2006 Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells Ann Surg Oncol 1 125 133 10.1245/ASO.2006.03.038
18. M Saito T Ebina M Koi T Yamaguchi Y Kawade N Ishida 1982 Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes Cell Immunol 1 187 192 10.1016/0008-8749(82)90102-2
19. Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ, the OK-432 Collaborative Study Group OK-432 Collaborative Study Group (2008) Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 1:107-115